214 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ambros IM, Tonini GP, Pötschger U, Gross N, Mosseri V, Beiske K, Berbegall AP, Bénard J, Bown N, Caron H, Combaret V, Couturier J, Defferrari R, Delattre O, Jeison M, et al. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable -Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1802132. PMID 32903140 DOI: 10.1200/JCO.18.02132  0.32
2019 van Wezel EM, van Zogchel LMJ, van Wijk J, Timmerman I, Vo NK, Zappeij-Kannegieter L, deCarolis B, Simon T, van Noesel MM, Molenaar JJ, van Groningen T, Versteeg R, Caron HN, van der Schoot CE, Koster J, et al. Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel. Jco Precision Oncology. 3. PMID 34036221 DOI: 10.1200/PO.18.00413  0.36
2017 Bate-Eya LT, Gierman HJ, Ebus ME, Koster J, Caron HN, Versteeg R, Dolman ME, Molenaar JJ. Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity. European Journal of Cancer (Oxford, England : 1990). 75: 63-72. PMID 28214660 DOI: 10.1016/J.Ejca.2016.12.019  0.36
2016 Bate-Eya LT, den Hartog IJ, van der Ploeg I, Schild L, Koster J, Santo EE, Westerhout EM, Versteeg R, Caron HN, Molenaar JJ, Dolman ME. High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition. Oncotarget. PMID 27056887 DOI: 10.18632/Oncotarget.8547  0.4
2016 van Wezel EM, Decarolis B, Stutterheim J, Zappeij-Kannegieter L, Berthold F, Schumacher-Kuckelkorn R, Simon T, Fiocco M, van Noesel MM, Caron HN, van der Schoot CE, Hero B, Tytgat GA. Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients. European Journal of Cancer (Oxford, England : 1990). 54: 149-158. PMID 26796600 DOI: 10.1016/J.Ejca.2015.11.007  0.4
2016 Bate-Eya LT, Hartog IJMd, Ploeg Ivd, Schild L, Koster J, Versteeg R, Caron HN, Molenaar JJ, Dolman MEM. Abstract B09: MCL-1 inhibition improves ABT199 efficacy for BCL-2-dependent neuroblastoma Cancer Research. 76. DOI: 10.1158/1538-7445.Pedca15-B09  0.36
2016 Eleveld TF, Schild L, Ebus ME, Sluis PGv, Westerhout EM, Caron HN, Koster JJB, Versteeg R, Molenaar JJ. Abstract A31: Activation of the RAS-MAPK pathway in primary neuroblastoma tumors is associated with poor prognosis Cancer Research. 76. DOI: 10.1158/1538-7445.Pedca15-A31  0.36
2015 Dolman ME, van der Ploeg I, Koster J, Bate-Eya LT, Versteeg R, Caron HN, Molenaar JJ. DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma Cells. Plos One. 10: e0145744. PMID 26716839 DOI: 10.1371/Journal.Pone.0145744  0.4
2015 Clement SC, Schoot RA, Slater O, Chisholm JC, Abela C, Balm AJ, van den Brekel MW, Breunis WB, Chang YC, Davila Fajardo R, Dunaway D, Gajdosova E, Gaze MN, Gupta S, Hartley B, ... ... Caron HN, et al. Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma. European Journal of Cancer (Oxford, England : 1990). 54: 1-10. PMID 26707591 DOI: 10.1016/j.ejca.2015.10.064  0.4
2015 Feijen EA, Leisenring WM, Stratton KL, Ness KK, van der Pal HJ, Caron HN, Armstrong GT, Green DM, Hudson MM, Oeffinger KC, Robison LL, Stovall M, Kremer LC, Chow EJ. Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26304888 DOI: 10.1200/Jco.2015.61.5187  0.4
2015 Schoot RA, Theunissen EA, Slater O, Lopez-Yurda M, Zuur CL, Gaze MN, Chang YC, Mandeville HC, Gains JE, Rajput K, Pieters BR, Davila Fajardo R, Talwar R, Caron HN, Balm AJ, et al. Hearing loss in survivors of childhood head and neck rhabdomyosarcoma; a long-term follow-up study. Clinical Otolaryngology : Official Journal of Ent-Uk ; Official Journal of Netherlands Society For Oto-Rhino-Laryngology & Cervico-Facial Surgery. PMID 26293165 DOI: 10.1111/coa.12527  0.4
2015 Aminkeng F, Bhavsar AP, Visscher H, Rassekh SR, Li Y, Lee JW, Brunham LR, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Amstutz U, Rieder MJ, Bernstein D, Carleton BC, et al. A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer. Nature Genetics. PMID 26237429 DOI: 10.1038/Ng.3374  0.4
2015 Visscher H, Rassekh SR, Sandor GS, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Rogers PC, Rieder MJ, Carleton BC, Hayden MR, Ross CJ. Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children. Pharmacogenomics. 16: 1065-76. PMID 26230641 DOI: 10.2217/Pgs.15.61  0.4
2015 Dolman ME, Poon E, Ebus ME, den Hartog IJ, van Noesel CJ, Jamin Y, Hallsworth A, Robinson SP, Petrie K, Sparidans RW, Kok RJ, Versteeg R, Caron HN, Chesler L, Molenaar JJ. Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26202950 DOI: 10.1158/1078-0432.Ccr-15-0313  0.4
2015 Schoot RA, van Ommen CH, Stijnen T, Tissing WJ, Michiels E, Abbink FC, Raphael MF, Heij HA, Lieverst JA, Spanjaard L, Zwaan CM, Caron HN, van de Wetering MD. Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: A randomised controlled multi-centre trial. European Journal of Cancer (Oxford, England : 1990). 51: 2031-8. PMID 26188849 DOI: 10.1016/j.ejca.2015.06.126  0.4
2015 Sieswerda E, Font-Gonzalez A, Dijkgraaf MG, Geskus RB, Heinen RC, van der Pal HJ, van Leeuwen FE, Caron HN, Kremer LC, Reitsma JB. Studying Hospitalizations and Mortality in the Netherlands: Feasible and Valid Using Two-Step Medical Record Linkage with Nationwide Registers. Plos One. 10: e0132444. PMID 26147988 DOI: 10.1371/journal.pone.0132444  0.4
2015 Eleveld TF, Oldridge DA, Bernard V, Koster J, Daage LC, Diskin SJ, Schild L, Bentahar NB, Bellini A, Chicard M, Lapouble E, Combaret V, Legoix-Né P, Michon J, Pugh TJ, ... ... Caron HN, et al. Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations. Nature Genetics. PMID 26121087 DOI: 10.1038/Ng.3333  0.4
2015 Schoot RA, Slater O, Ronckers CM, Zwinderman AH, Balm AJ, Hartley B, van den Brekel MW, Gupta S, Saeed P, Gajdosova E, Pieters BR, Gaze MN, Mandeville HC, Fajardo RD, Chang YC, ... ... Caron HN, et al. Adverse events of local treatment in long-term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatment. European Journal of Cancer (Oxford, England : 1990). 51: 1424-34. PMID 25998323 DOI: 10.1016/j.ejca.2015.02.010  0.4
2015 Kraal KC, Tytgat GA, van Eck-Smit BL, Kam B, Caron HN, van Noesel M. Upfront treatment of high-risk neuroblastoma with a combination of (131) I-MIBG and Topotecan. Pediatric Blood & Cancer. 62: 1886-91. PMID 25981988 DOI: 10.1002/Pbc.25580  0.4
2015 van Wezel EM, Stutterheim J, Vree F, Zappeij-Kannegieter L, Decarolis B, Hero B, Berthold F, Schumacher-Kuckelkorn R, Simon T, Fiocco M, Voermans C, van Noesel MM, Caron HN, van der Schoot CE, Tytgat GA, et al. Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma. Pediatric Blood & Cancer. 62: 1368-73. PMID 25939774 DOI: 10.1002/Pbc.25507  0.4
2015 Clement SC, van Rijn RR, van Eck-Smit BL, van Trotsenburg AS, Caron HN, Tytgat GA, van Santen HM. Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma. European Journal of Nuclear Medicine and Molecular Imaging. 42: 706-15. PMID 25512056 DOI: 10.1007/S00259-014-2967-4  0.4
2015 Ariës IM, van den Dungen RE, Koudijs MJ, Cuppen E, Voest E, Molenaar JJ, Caron HN, Pieters R, den Boer ML. Towards personalized therapy in pediatric acute lymphoblastic leukemia: RAS mutations and prednisolone resistance. Haematologica. 100: e132-6. PMID 25480501 DOI: 10.1182/Blood.V124.21.372.372  0.4
2015 van Wezel EM, Zwijnenburg D, Zappeij-Kannegieter L, Bus E, van Noesel MM, Molenaar JJ, Versteeg R, Fiocco M, Caron HN, van der Schoot CE, Koster J, Tytgat GA. Whole-genome sequencing identifies patient-specific DNA minimal residual disease markers in neuroblastoma. The Journal of Molecular Diagnostics : Jmd. 17: 43-52. PMID 25445214 DOI: 10.1016/J.Jmoldx.2014.09.005  0.4
2015 van der Pal HJ, van Dijk IW, Geskus RB, Kok WE, Koolen M, Sieswerda E, Oldenburger F, Koning CC, van Leeuwen FE, Caron HN, Kremer LC, van Dalen EC. Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study. International Journal of Radiation Oncology, Biology, Physics. 91: 213-22. PMID 25442333 DOI: 10.1016/j.ijrobp.2014.09.010  0.4
2015 Bleeker G, van Eck-Smit BL, Zwinderman KH, Versteeg R, van Noesel MM, Kam BL, Kaspers GJ, van Schie A, Kreissman SG, Yanik G, Hero B, Schmidt M, Laureys G, Lambert B, Øra I, ... ... Caron HN, et al. MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis. European Journal of Nuclear Medicine and Molecular Imaging. 42: 222-30. PMID 25267348 DOI: 10.1007/s00259-014-2909-1  0.4
2015 Oldridge DA, Eleveld TF, Bernard V, Koster J, Daage LC, Diskin SJ, Schild L, Bentahar NB, Bellini A, Chicard M, Lapouble E, Combaret V, Legoix-Né P, Michon J, Pugh TJ, ... ... Caron HN, et al. Abstract 2980: Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations Cancer Research. 75: 2980-2980. DOI: 10.1158/1538-7445.Am2015-2980  0.36
2014 van Dalen EC, Raphaël MF, Caron HN, Kremer LC. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. The Cochrane Database of Systematic Reviews. 9: CD006647. PMID 25188452 DOI: 10.1002/14651858.CD006647.pub4  0.4
2014 Clement SC, Meeteren AY, Kremer LC, van Trotsenburg AS, Caron HN, van Santen HM. High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programs. Pediatric Blood & Cancer. 61: 2285-9. PMID 25131941 DOI: 10.1002/Pbc.25176  0.4
2014 van Dijk IW, van Os RM, van de Kamer JB, Franken NA, van der Pal HJ, Koning CC, Caron HN, Ronckers CM, Kremer LC. The use of equivalent radiation dose in the evaluation of late effects after childhood cancer treatment. Journal of Cancer Survivorship : Research and Practice. 8: 638-46. PMID 24927790 DOI: 10.1007/s11764-014-0373-3  0.4
2014 Schepers SA, Engelen VE, Haverman L, Caron HN, Hoogerbrugge PM, Kaspers GJ, Egeler RM, Grootenhuis MA. Patient reported outcomes in pediatric oncology practice: suggestions for future usage by parents and pediatric oncologists. Pediatric Blood & Cancer. 61: 1707-10. PMID 24648289 DOI: 10.1002/pbc.25034  0.4
2014 Bate-Eya LT, Ebus ME, Koster J, den Hartog IJ, Zwijnenburg DA, Schild L, van der Ploeg I, Dolman ME, Caron HN, Versteeg R, Molenaar JJ. Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours. European Journal of Cancer (Oxford, England : 1990). 50: 628-37. PMID 24321263 DOI: 10.1016/J.Ejca.2013.11.015  0.4
2014 Eleveld TF, Schild L, Koster J, Zwijnenburg D, Ebus ME, van PS, Schulte JH, Caron HN, Versteeg R, Molenaar JJ. Abstract B41: Whole genome sequencing identifies tumor evolution events in relapse neuroblastoma Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-B41  0.36
2013 Mulder RL, Knijnenburg SL, Geskus RB, van Dalen EC, van der Pal HJ, Koning CC, Bouts AH, Caron HN, Kremer LC. Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1736-46. PMID 24064520 DOI: 10.1158/1055-9965.EPI-13-0036  0.4
2013 Schoot RA, McHugh K, van Rijn RR, Kremer LC, Chisholm JC, Caron HN, Merks JH. Response assessment in pediatric rhabdomyosarcoma: can response evaluation criteria in solid tumors replace three-dimensional volume assessments? Radiology. 269: 870-8. PMID 23985275 DOI: 10.1148/Radiol.13122607  0.4
2013 Yalçin B, Kremer LC, Caron HN, van Dalen EC. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. The Cochrane Database of Systematic Reviews. 8: CD006301. PMID 23970444 DOI: 10.1002/14651858.CD006301.pub3  0.4
2013 Bleeker G, Schoot RA, Caron HN, de Kraker J, Hoefnagel CA, van Eck BL, Tytgat GA. Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis. European Journal of Nuclear Medicine and Molecular Imaging. 40: 1711-7. PMID 23921531 DOI: 10.1007/s00259-013-2510-z  0.4
2013 Hopman SM, Merks JH, de Borgie CA, Aalfs CM, Biesecker LG, Cole T, Eng C, Legius E, Maher ER, van Noesel MM, Verloes A, Viskochil DH, Wagner A, Weksberg R, Caron HN, et al. The development of a clinical screening instrument for tumour predisposition syndromes in childhood cancer patients. European Journal of Cancer (Oxford, England : 1990). 49: 3247-54. PMID 23855994 DOI: 10.1016/J.Ejca.2013.06.015  0.4
2013 Hartsink-Segers SA, Exalto C, Allen M, Williamson D, Clifford SC, Horstmann M, Caron HN, Pieters R, Den Boer ML. Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cells. Haematologica. 98: 1539-46. PMID 23753023 DOI: 10.3324/haematol.2013.084434  0.4
2013 Schoot RA, Bleeker G, Caron HN, van Eck BL, Heij HA, de Kraker J, Tytgat GA. The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma. European Journal of Nuclear Medicine and Molecular Imaging. 40: 1516-22. PMID 23740371 DOI: 10.1007/s00259-013-2455-2  0.4
2013 Sieswerda E, Mulder RL, van Dijk IW, van Dalen EC, Knijnenburg SL, van der Pal HJ, Mud MS, Heinen RC, Caron HN, Kremer LC. The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availability. Journal of Cancer Survivorship : Research and Practice. 7: 439-54. PMID 23625157 DOI: 10.1007/s11764-013-0283-9  0.4
2013 Visscher H, Ross CJ, Rassekh SR, Sandor GS, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Rogers PC, Rieder MJ, Carleton BC, Hayden MR. Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatric Blood & Cancer. 60: 1375-81. PMID 23441093 DOI: 10.1002/Pbc.24505  0.4
2013 Knops RR, van Dalen EC, Mulder RL, Leclercq E, Knijnenburg SL, Kaspers GJ, Pieters R, Caron HN, Kremer LC. The volume effect in paediatric oncology: a systematic review. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 1749-53. PMID 23378538 DOI: 10.1093/annonc/mds656  0.4
2013 Kremer LC, Mulder RL, Oeffinger KC, Bhatia S, Landier W, Levitt G, Constine LS, Wallace WH, Caron HN, Armenian SH, Skinner R, Hudson MM. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatric Blood & Cancer. 60: 543-9. PMID 23281199 DOI: 10.1002/pbc.24445  0.4
2013 Knijnenburg SL, Raemaekers S, van den Berg H, van Dijk IW, Lieverst JA, van der Pal HJ, Jaspers MW, Caron HN, Kremer LC, van Santen HM. Final height in survivors of childhood cancer compared with Height Standard Deviation Scores at diagnosis. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 1119-26. PMID 23139260 DOI: 10.1093/Annonc/Mds580  0.4
2013 Knijnenburg SL, Kremer LC, Versluys AB, Braam KI, Mud MS, van der Pal HJ, Caron HN, Jaspers MW. Evaluation of a patient information website for childhood cancer survivors. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 21: 919-26. PMID 23007883 DOI: 10.1007/s00520-012-1604-7  0.4
2013 van Dijk IW, Cardous-Ubbink MC, van der Pal HJ, Heinen RC, van Leeuwen FE, Oldenburger F, van Os RM, Ronckers CM, Schouten-van Meeteren AY, Caron HN, Koning CC, Kremer LC. Dose-effect relationships for adverse events after cranial radiation therapy in long-term childhood cancer survivors. International Journal of Radiation Oncology, Biology, Physics. 85: 768-75. PMID 22954771 DOI: 10.1016/j.ijrobp.2012.07.008  0.4
2013 Hartsink-Segers SA, Zwaan CM, Exalto C, Luijendijk MW, Calvert VS, Petricoin EF, Evans WE, Reinhardt D, de Haas V, Hedtjärn M, Hansen BR, Koch T, Caron HN, Pieters R, Den Boer ML. Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target. Leukemia. 27: 560-8. PMID 22940834 DOI: 10.1038/leu.2012.256  0.4
2013 Mulder RL, Kremer LC, Koot BG, Benninga MA, Knijnenburg SL, van der Pal HJ, Koning CC, Oldenburger F, Wilde JC, Taminiau JA, Caron HN, van Dalen EC. Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors. European Journal of Cancer (Oxford, England : 1990). 49: 185-93. PMID 22901831 DOI: 10.1016/j.ejca.2012.07.009  0.4
2013 Maurice-Stam H, Verhoof EJ, Caron HN, Grootenhuis MA. Are survivors of childhood cancer with an unfavourable psychosocial developmental trajectory more likely to apply for disability benefits? Psycho-Oncology. 22: 708-14. PMID 22213575 DOI: 10.1002/Pon.2112  0.4
2013 Molenaar JJ, Koster J, Ebus M, Zwijnenburg DA, Sluis Pv, Lamers F, Schild L, Ploeg Ivd, Caron HN, Versteeg R. L04.05 Targeted Drug Development In Pediatric Cancer Despite A Low Frequency Of Tumor Driving Mutations Annals of Oncology. 24. DOI: 10.1093/Annonc/Mdt042.19  0.36
2012 Molenaar JJ, Domingo-Fernández R, Ebus ME, Lindner S, Koster J, Drabek K, Mestdagh P, van Sluis P, Valentijn LJ, van Nes J, Broekmans M, Haneveld F, Volckmann R, Bray I, Heukamp L, ... ... Caron HN, et al. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nature Genetics. 44: 1199-206. PMID 23042116 DOI: 10.1038/Ng.2436  0.4
2012 Knijnenburg SL, Jaspers MW, van der Pal HJ, Schouten-van Meeteren AY, Bouts AH, Lieverst JA, Bökenkamp A, Koning CC, Oldenburger F, Wilde JC, van Leeuwen FE, Caron HN, Kremer LC. Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 1416-27. PMID 22822016 DOI: 10.2215/Cjn.09620911  0.4
2012 Lamers F, Schild L, Koster J, Speleman F, Øra I, Westerhout EM, van Sluis P, Versteeg R, Caron HN, Molenaar JJ. Identification of BIRC6 as a novel intervention target for neuroblastoma therapy. Bmc Cancer. 12: 285. PMID 22788920 DOI: 10.1186/1471-2407-12-285  0.4
2012 Schoot RA, van Ommen CH, Caron HN, Tissing WJ, van de Wetering MD. Accrual in supportive care trials in pediatric oncology, a challenge! Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 20: 3149-53. PMID 22476398 DOI: 10.1007/S00520-012-1447-2  0.4
2012 van der Pal HJ, van Dalen EC, van Delden E, van Dijk IW, Kok WE, Geskus RB, Sieswerda E, Oldenburger F, Koning CC, van Leeuwen FE, Caron HN, Kremer LC. High risk of symptomatic cardiac events in childhood cancer survivors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 1429-37. PMID 22473161 DOI: 10.1200/Jco.2010.33.4730  0.4
2012 Molenaar JJ, Koster J, Zwijnenburg DA, van Sluis P, Valentijn LJ, van der Ploeg I, Hamdi M, van Nes J, Westerman BA, van Arkel J, Ebus ME, Haneveld F, Lakeman A, Schild L, Molenaar P, ... ... Caron HN, et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature. 483: 589-93. PMID 22367537 DOI: 10.1038/Nature10910  0.4
2012 Lamers F, Schild L, den Hartog IJ, Ebus ME, Westerhout EM, Ora I, Koster J, Versteeg R, Caron HN, Molenaar JJ. Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth. European Journal of Cancer (Oxford, England : 1990). 48: 3093-103. PMID 22366560 DOI: 10.1016/J.Ejca.2012.01.037  0.4
2012 Knops RR, Hulscher ME, Hermens RP, Hilbink-Smolders M, Loeffen JL, Kollen WJ, Kaspers GJ, Caron HN, Kremer LC. High-quality care for all children with cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 23: 1906-11. PMID 22317768 DOI: 10.1093/annonc/mdr601  0.4
2012 Sieswerda E, Postma A, van Dalen EC, van der Pal HJ, Tissing WJ, Rammeloo LA, Kok WE, van Leeuwen FE, Caron HN, Kremer LC. The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 23: 2191-8. PMID 22312159 DOI: 10.1093/annonc/mdr595  0.4
2012 Engelen V, van Zwieten M, Koopman H, Detmar S, Caron H, Brons P, Egeler M, Kaspers GJ, Grootenhuis M. The influence of patient reported outcomes on the discussion of psychosocial issues in children with cancer. Pediatric Blood & Cancer. 59: 161-6. PMID 22271750 DOI: 10.1002/pbc.24089  0.36
2012 de Lijster MS, Bergevoet RM, van Dalen EC, Michiels EM, Caron HN, Kremer LC, Aronson DC. Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children. The Cochrane Database of Systematic Reviews. 1: CD008403. PMID 22258984 DOI: 10.1002/14651858.CD008403.pub2  0.4
2012 Stutterheim J, Zappeij-Kannegieter L, Ora I, van Sluis PG, Bras J, den Ouden E, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA. Stability of PCR targets for monitoring minimal residual disease in neuroblastoma. The Journal of Molecular Diagnostics : Jmd. 14: 168-75. PMID 22251610 DOI: 10.1016/j.jmoldx.2011.12.002  0.4
2012 Besançon OG, Tytgat GA, Meinsma R, Leen R, Hoebink J, Kalayda GV, Jaehde U, Caron HN, van Kuilenburg AB. Synergistic interaction between cisplatin and gemcitabine in neuroblastoma cell lines and multicellular tumor spheroids. Cancer Letters. 319: 23-30. PMID 22182450 DOI: 10.1016/J.Canlet.2011.12.016  0.4
2012 Stutterheim J, Ichou FA, den Ouden E, Versteeg R, Caron HN, Tytgat GA, van der Schoot CE. Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 808-14. PMID 22142825 DOI: 10.1158/1078-0432.Ccr-11-0849  0.4
2012 Lamers F, Schild L, Koster J, Versteeg R, Caron HN, Molenaar JJ. Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression. European Journal of Cancer (Oxford, England : 1990). 48: 763-71. PMID 22088485 DOI: 10.1016/J.Ejca.2011.10.012  0.4
2012 Molenaar JJ, Koster J, Ebus ME, van Sluis P, Westerhout EM, de Preter K, Gisselsson D, Øra I, Speleman F, Caron HN, Versteeg R. Copy number defects of G1-cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis. Genes, Chromosomes & Cancer. 51: 10-9. PMID 22034077 DOI: 10.1002/Gcc.20926  0.4
2012 Visscher H, Ross CJ, Rassekh SR, Barhdadi A, Dubé MP, Al-Saloos H, Sandor GS, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Brown AM, Rogers PC, Phillips MS, Rieder MJ, et al. Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 1422-8. PMID 21900104 DOI: 10.1200/Jco.2010.34.3467  0.4
2012 Santo EE, Ebus ME, Koster J, Schulte JH, Lakeman A, van Sluis P, Vermeulen J, Gisselsson D, Øra I, Lindner S, Buckley PG, Stallings RL, Vandesompele J, Eggert A, Caron HN, et al. Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma. Oncogene. 31: 1571-81. PMID 21860421 DOI: 10.1038/Onc.2011.344  0.4
2012 Lindner S, Molenaar J, Thor T, Sprüssel A, Caron H, Versteeg R, Schramm A, Eggert A, Schulte J. LIN28B drives neuroblastoma oncogenesis through let7-MYCN signaling Klinische Padiatrie. 224. DOI: 10.1055/S-0032-1310498  0.36
2012 Sieswerda E, van Dalen EC, Postma A, Cheuk DKL, Caron HN, Kremer LCM. Cochrane Review: Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer Evidence-Based Child Health. 7: 1857-1902. DOI: 10.1002/ebch.1885  0.4
2011 Sieswerda E, van Dalen EC, Postma A, Cheuk DK, Caron HN, Kremer LC. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer. The Cochrane Database of Systematic Reviews. CD008011. PMID 21901716 DOI: 10.1002/14651858.CD008011.pub2  0.4
2011 Lamers F, van der Ploeg I, Schild L, Ebus ME, Koster J, Hansen BR, Koch T, Versteeg R, Caron HN, Molenaar JJ. Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe. Endocrine-Related Cancer. 18: 657-68. PMID 21859926 DOI: 10.1530/Erc-11-0207  0.4
2011 Mulder RL, Thönissen NM, van der Pal HJ, Bresser P, Hanselaar W, Koning CC, Oldenburger F, Heij HA, Caron HN, Kremer LC. Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancer. Thorax. 66: 1065-71. PMID 21803931 DOI: 10.1136/thoraxjnl-2011-200618  0.4
2011 Cuperus R, van Kuilenburg AB, Leen R, Bras J, Caron HN, Tytgat GA. Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids. Free Radical Biology & Medicine. 51: 1213-20. PMID 21741474 DOI: 10.1016/J.Freeradbiomed.2011.06.019  0.4
2011 Mulder RL, van Dalen EC, Van den Hof M, Bresters D, Koot BG, Castellino SM, Loke Y, Leclercq E, Post PN, Caron HN, Postma A, Kremer LC. Hepatic late adverse effects after antineoplastic treatment for childhood cancer. The Cochrane Database of Systematic Reviews. CD008205. PMID 21735424 DOI: 10.1002/14651858.CD008205.pub2  0.4
2011 van Dalen EC, Caron HN, Dickinson HO, Kremer LC. Cardioprotective interventions for cancer patients receiving anthracyclines. The Cochrane Database of Systematic Reviews. CD003917. PMID 21678342 DOI: 10.1002/14651858.CD003917.pub4  0.4
2011 Frakking FN, Israëls J, Kremer LC, Kuijpers TW, Caron HN, van de Wetering MD. Mannose-binding lectin (MBL) and the risk for febrile neutropenia and infection in pediatric oncology patients with chemotherapy. Pediatric Blood & Cancer. 57: 89-96. PMID 21557458 DOI: 10.1002/pbc.22901  0.4
2011 Sieswerda E, Kremer LC, Caron HN, van Dalen EC. The use of liposomal anthracycline analogues for childhood malignancies: A systematic review. European Journal of Cancer (Oxford, England : 1990). 47: 2000-8. PMID 21514819 DOI: 10.1016/j.ejca.2011.03.024  0.4
2011 Tromp K, Claessens JJ, Knijnenburg SL, van der Pal HJ, van Leeuwen FE, Caron HN, Beerendonk CC, Kremer LC. Reproductive status in adult male long-term survivors of childhood cancer. Human Reproduction (Oxford, England). 26: 1775-83. PMID 21489977 DOI: 10.1093/humrep/der113  0.4
2011 Frakking FN, Brouwer N, Dolman KM, van Woensel JB, Caron HN, Kuijpers TW, van de Wetering MD. Mannose-binding lectin (MBL) as prognostic factor in paediatric oncology patients. Clinical and Experimental Immunology. 165: 51-9. PMID 21488869 DOI: 10.1111/j.1365-2249.2011.04398.x  0.4
2011 Stutterheim J, Zappeij-Kannegieter L, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA. The prognostic value of fast molecular response of marrow disease in patients aged over 1 year with stage 4 neuroblastoma. European Journal of Cancer (Oxford, England : 1990). 47: 1193-202. PMID 21429738 DOI: 10.1016/j.ejca.2011.02.003  0.4
2011 van Dalen EC, Raphaël MF, Caron HN, Kremer LC. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. The Cochrane Database of Systematic Reviews. CD006647. PMID 21249679 DOI: 10.1002/14651858.CD006647.pub3  0.4
2011 van Dalen EC, van den Berg H, Raphaël MF, Caron HN, Kremer LC. Should anthracyclines and dexrazoxane be used for children with cancer? The Lancet. Oncology. 12: 12-3. PMID 21195321 DOI: 10.1016/S1470-2045(10)70301-6  0.4
2011 Van Der Pal HJ, Van Dalen EC, Hauptmann M, Kok WE, Caron HN, Van Den Bos C, Oldenburger F, Koning CC, Van Leeuwen FE, Kremer LC. Cardiac function in 5-year survivors of childhood cancer: Reply Archives of Internal Medicine. 171: 264-265. DOI: 10.1001/Archinternmed.2010.534  0.4
2010 De Brouwer S, De Preter K, Kumps C, Zabrocki P, Porcu M, Westerhout EM, Lakeman A, Vandesompele J, Hoebeeck J, Van Maerken T, De Paepe A, Laureys G, Schulte JH, Schramm A, Van Den Broecke C, ... ... Caron H, et al. Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4353-62. PMID 20719933 DOI: 10.1158/1078-0432.Ccr-09-2660  0.36
2010 van der Pal HJ, van Dalen EC, Hauptmann M, Kok WE, Caron HN, van den Bos C, Oldenburger F, Koning CC, van Leeuwen FE, Kremer LC. Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. Archives of Internal Medicine. 170: 1247-55. PMID 20660845 DOI: 10.1001/Archinternmed.2010.233  0.4
2010 Hölzel M, Huang S, Koster J, Ora I, Lakeman A, Caron H, Nijkamp W, Xie J, Callens T, Asgharzadeh S, Seeger RC, Messiaen L, Versteeg R, Bernards R. NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome. Cell. 142: 218-29. PMID 20655465 DOI: 10.1016/J.Cell.2010.06.004  0.4
2010 Fardin P, Barla A, Mosci S, Rosasco L, Verri A, Versteeg R, Caron HN, Molenaar JJ, Ora I, Eva A, Puppo M, Varesio L. A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients. Molecular Cancer. 9: 185. PMID 20624283 DOI: 10.1186/1476-4598-9-185  0.4
2010 Yalçin B, Kremer LC, Caron HN, van Dalen EC. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. The Cochrane Database of Systematic Reviews. CD006301. PMID 20464740 DOI: 10.1002/14651858.CD006301.pub2  0.4
2010 Israels T, Damen CW, Cole M, van Geloven N, Boddy AV, Caron HN, Beijnen JH, Molyneux EM, Veal GJ. Malnourished Malawian patients presenting with large Wilms tumours have a decreased vincristine clearance rate. European Journal of Cancer (Oxford, England : 1990). 46: 1841-7. PMID 20382523 DOI: 10.1016/J.Ejca.2010.03.002  0.4
2010 de Lijster MS, Bergevoet RM, van Dalen EC, Michiels EM, Caron HN, Kremer LC, Aronson DC. Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children. The Cochrane Database of Systematic Reviews. CD008403. PMID 20238368 DOI: 10.1002/14651858.CD008403  0.4
2010 van Dalen EC, Michiels EM, Caron HN, Kremer LC. Different anthracycline derivates for reducing cardiotoxicity in cancer patients. The Cochrane Database of Systematic Reviews. CD005006. PMID 20238335 DOI: 10.1002/14651858.CD005006.pub3  0.4
2010 Caron HN. Are thoracic neuroblastomas really different? Pediatric Blood & Cancer. 54: 867. PMID 20232434 DOI: 10.1002/pbc.22470  0.4
2010 Zwaan CM, Kearns P, Caron H, Verschuur A, Riccardi R, Boos J, Doz F, Geoerger B, Morland B, Vassal G. The role of the 'innovative therapies for children with cancer' (ITCC) European consortium. Cancer Treatment Reviews. 36: 328-34. PMID 20231057 DOI: 10.1016/j.ctrv.2010.02.008  0.4
2010 Molenaar JJ, Ebus ME, Koster J, Santo E, Geerts D, Versteeg R, Caron HN. Cyclin D1 is a direct transcriptional target of GATA3 in neuroblastoma tumor cells. Oncogene. 29: 2739-45. PMID 20154722 DOI: 10.1038/Onc.2010.21  0.4
2010 van Dijk IW, Oldenburger F, Cardous-Ubbink MC, Geenen MM, Heinen RC, de Kraker J, van Leeuwen FE, van der Pal HJ, Caron HN, Koning CC, Kremer LC. Evaluation of late adverse events in long-term wilms' tumor survivors. International Journal of Radiation Oncology, Biology, Physics. 78: 370-8. PMID 20137867 DOI: 10.1016/j.ijrobp.2009.08.016  0.4
2010 Cardous-Ubbink MC, Geenen MM, Schade KJ, Heinen RC, Caron HN, Kremer LC, Van Leeuwen FE. Hypertension in long-term survivors of childhood cancer: a nested case-control study. European Journal of Cancer (Oxford, England : 1990). 46: 782-90. PMID 20117927 DOI: 10.1016/j.ejca.2010.01.002  0.4
2010 Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Hematology/Oncology Clinics of North America. 24: 65-86. PMID 20113896 DOI: 10.1016/j.hoc.2009.11.011  0.4
2010 Geerts D, Koster J, Albert D, Koomoa DL, Feith DJ, Pegg AE, Volckmann R, Caron H, Versteeg R, Bachmann AS. The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification. International Journal of Cancer. 126: 2012-24. PMID 19960435 DOI: 10.1002/Ijc.25074  0.4
2010 Cuperus R, Leen R, Tytgat GA, Caron HN, van Kuilenburg AB. Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma. Cellular and Molecular Life Sciences : Cmls. 67: 807-16. PMID 19941060 DOI: 10.1007/S00018-009-0212-2  0.4
2010 van Dalen EC, Mulder RL, Caron HN, Kremer LC. Response to "cancer care in the pediatric surgical patient: a paradigm to abolish volume-outcome disparities in surgery". Surgery. 147: 310-1. PMID 19767049 DOI: 10.1016/j.surg.2009.07.006  0.4
2010 Holst MI, Westerhout E, Kool M, Versteeg R, Caron H, Clifford S, Rutkowski S, Pietsch T. Abstract LB-384: Targeting overexpressed Aurora kinases in childhood medulloblastoma: Antiproliferative effects of small molecule inhibitors ZM44739, VX680 and shRNA Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-384  0.36
2010 Hölzel M, Huang S, Koster J, Ora I, Lakeman A, Caron HN, Callens T, Xie J, Nijkamp W, Asgharzadeh S, Seeger RC, Messiaen L, Versteeg R, Bernards R. Abstract A30: NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcme10-A30  0.36
2009 Israëls T, Borgstein E, Jamali M, de Kraker J, Caron HN, Molyneux EM. Acute malnutrition is common in Malawian patients with a Wilms tumour: A role for peanut butter. Pediatric Blood & Cancer. 53: 1221-6. PMID 19821536 DOI: 10.1002/pbc.22158  0.4
2009 van Dalen EC, van der Pal HJ, Caron HN, Kremer LC. Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy. The Cochrane Database of Systematic Reviews. CD005008. PMID 19821337 DOI: 10.1002/14651858.CD005008.pub3  0.4
2009 Mulder RL, Kremer LC, van Santen HM, Ket JL, van Trotsenburg AS, Koning CC, Schouten-van Meeteren AY, Caron HN, Neggers SJ, van Dalen EC. Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review. Cancer Treatment Reviews. 35: 616-32. PMID 19640651 DOI: 10.1016/j.ctrv.2009.06.004  0.4
2009 Maurice-Stam H, Oort FJ, Last BF, Brons PP, Caron HN, Grootenhuis MA. School-aged children after the end of successful treatment of non-central nervous system cancer: longitudinal assessment of health-related quality of life, anxiety and coping. European Journal of Cancer Care. 18: 401-10. PMID 19594611 DOI: 10.1111/j.1365-2354.2008.01041.x  0.4
2009 Israëls T, Molyneux EM, Caron HN, Jamali M, Banda K, Bras H, Kamiza S, Borgstein E, de Kraker J. Preoperative chemotherapy for patients with Wilms tumor in Malawi is feasible and efficacious. Pediatric Blood & Cancer. 53: 584-9. PMID 19533658 DOI: 10.1002/pbc.22138  0.4
2009 Molenaar JJ, Ebus ME, Geerts D, Koster J, Lamers F, Valentijn LJ, Westerhout EM, Versteeg R, Caron HN. Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 12968-73. PMID 19525400 DOI: 10.1073/Pnas.0901418106  0.4
2009 Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Yalcin B, Dee R, van Noesel MM, Berthold F, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA. Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers. Clinical Chemistry. 55: 1316-26. PMID 19460840 DOI: 10.1373/clinchem.2008.117945  0.4
2009 Israëls T, van de Wetering MD, Hesseling P, van Geloven N, Caron HN, Molyneux EM. Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi. Pediatric Blood & Cancer. 53: 47-52. PMID 19338050 DOI: 10.1002/pbc.22032  0.4
2009 van Dalen EC, Raphaël MF, Caron HN, Kremer LC. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer. The Cochrane Database of Systematic Reviews. CD006647. PMID 19160293 DOI: 10.1002/14651858.CD006647.pub2  0.4
2009 Frakking FN, Brouwer N, van de Wetering MD, Budde IK, Strengers PF, Huitema AD, Laursen I, Houen G, Caron HN, Dolman KM, Kuijpers TW. Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaenia. European Journal of Cancer (Oxford, England : 1990). 45: 505-12. PMID 19121580 DOI: 10.1016/j.ejca.2008.11.036  0.4
2009 van Engelen K, Merks JH, Lam J, Kremer LC, Backes M, Baars MJ, van der Pal HJ, Postma AV, Versteeg R, Caron HN, Mulder BJ. Prevalence of congenital heart defects in neuroblastoma patients: a cohort study and systematic review of literature. European Journal of Pediatrics. 168: 1081-90. PMID 19089449 DOI: 10.1007/S00431-008-0891-Y  0.4
2009 Ten Bruggencate MJ, Kremer LC, Caron HN, Knops AM, van Dalen EC. Pediatric oncologists and evidence-based medicine: a postal survey in The Netherlands. Pediatric Blood & Cancer. 52: 231-6. PMID 19021222 DOI: 10.1002/Pbc.21844  0.4
2009 Caron HN, Westerhout EM, Molenaar JJ, den MLB, Clifford SC, Delattre O, Geoerger B, Lanvers C, Pietsch T, Scotlandi K, Sera M, Shipley J, Vassal G, Versteeg R, Verschuur A. Abstract C116: The KidsCancerKinome: Validation of drug targets for high risk childhood cancers Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-C116  0.36
2009 Westerhout EM, Kool M, Molenaar JJ, den MLB, Clifford SC, Delattre O, Geoerger B, Lanvers C, Pietsch T, Serra M, Shipley J, Vassal G, Versteeg R, Verschuur AC, Caron HN. Abstract C115: The KidsCancerKinome: Validation of Aurora kinases as potential drug targets in pediatric tumors Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-C115  0.36
2009 Molenaar JJ, Westerhout EM, den MLB, Clifford SC, Delattre O, Geoerger B, Lanvers C, Pietsch T, Serra M, Shipley J, Vassal G, Versteeg R, Verschuur AC, Caron HN. Abstract C114: The KidsCancerKinome: Validation of CDK2 as potential drug target in pediatric tumors Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-C114  0.36
2008 Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Kleijn I, Dee R, Hooft L, van Noesel MM, Bierings M, Berthold F, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA. PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5443-9. PMID 18838715 DOI: 10.1200/Jco.2007.13.6531  0.4
2008 Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J, Mrsić A, Ylstra B, Grajkowska W, Hartmann W, Pietsch T, et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. Plos One. 3: e3088. PMID 18769486 DOI: 10.1371/Journal.Pone.0003088  0.4
2008 Israëls T, Chirambo C, Caron HN, Molyneux EM. Nutritional status at admission of children with cancer in Malawi. Pediatric Blood & Cancer. 51: 626-8. PMID 18668514 DOI: 10.1002/pbc.21697  0.4
2008 de Haas T, Hasselt N, Troost D, Caron H, Popovic M, Zadravec-Zaletel L, Grajkowska W, Perek M, Osterheld MC, Ellison D, Baas F, Versteeg R, Kool M. Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4154-60. PMID 18593994 DOI: 10.1158/1078-0432.Ccr-07-4159  0.4
2008 van Dalen EC, Caron HN, Dickinson HO, Kremer LC. Cardioprotective interventions for cancer patients receiving anthracyclines. The Cochrane Database of Systematic Reviews. CD003917. PMID 18425895 DOI: 10.1002/14651858.CD003917.pub3  0.4
2008 Cuperus R, Tytgat GA, Leen R, Brites P, Bras J, Caron HN, Van Kuilenburg AB. Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids. International Journal of Oncology. 32: 1011-9. PMID 18425327 DOI: 10.3892/Ijo.32.5.1011  0.4
2008 Molenaar JJ, Ebus ME, Koster J, van Sluis P, van Noesel CJ, Versteeg R, Caron HN. Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Research. 68: 2599-609. PMID 18413728 DOI: 10.1158/0008-5472.Can-07-5032  0.4
2008 de Kraker J, Hoefnagel KA, Verschuur AC, van Eck B, van Santen HM, Caron HN. Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age. European Journal of Cancer (Oxford, England : 1990). 44: 551-6. PMID 18267358 DOI: 10.1016/j.ejca.2008.01.010  0.4
2008 Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Pediatric Clinics of North America. 55: 97-120, x. PMID 18242317 DOI: 10.1016/j.pcl.2007.10.014  0.4
2008 Merks JH, Ozgen HM, Koster J, Zwinderman AH, Caron HN, Hennekam RC. Prevalence and patterns of morphological abnormalities in patients with childhood cancer. Jama. 299: 61-9. PMID 18167407 DOI: 10.1001/Jama.2007.66  0.4
2008 Koppen A, Ait-Aissa R, Koster J, Øra I, Bras J, Van Sluis PG, Caron H, Versteeg R, Valentijn LJ. Dickkopf-3 expression is a marker for neuroblasts tumor maturation and is down-regulated by MYCN International Journal of Cancer. 122: 1455-1464. PMID 18059033 DOI: 10.1002/Ijc.23180  0.4
2008 Maurice-Stam H, Oort FJ, Last BF, Brons PP, Caron HN, Grootenhuis MA. Longitudinal assessment of health-related quality of life in preschool children with non-CNS cancer after the end of successful treatment. Pediatric Blood & Cancer. 50: 1047-51. PMID 17914734 DOI: 10.1002/Pbc.21374  0.4
2007 Maurice-Stam H, Grootenhuis MA, Caron HN, Last BF. Course of life of survivors of childhood cancer is related to quality of life in young adulthood. Journal of Psychosocial Oncology. 25: 43-58. PMID 19341013 DOI: 10.1300/J077v25n03_03  0.4
2007 Koppen A, Ait-Aissa R, Koster J, van Sluis PG, Ora I, Caron HN, Volckmann R, Versteeg R, Valentijn LJ. Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma. European Journal of Cancer (Oxford, England : 1990). 43: 2413-22. PMID 17826980 DOI: 10.1016/J.Ejca.2007.07.024  0.4
2007 Maurice-Stam H, Grootenhuis MA, Brons PP, Caron HN, Last BF. Psychosocial indicators of health-related quality of life in children with cancer 2 months after end of successful treatment. Journal of Pediatric Hematology/Oncology. 29: 540-50. PMID 17762495 DOI: 10.1097/Mph.0B013E3181256B66  0.4
2007 van de Wetering MD, Weggelaar N, Offringa M, Caron HN, Kuijpers TW. Granulocyte transfusions in neutropaenic children: a systematic review of the literature. European Journal of Cancer (Oxford, England : 1990). 43: 2082-92. PMID 17761413 DOI: 10.1016/j.ejca.2007.07.018  0.4
2007 Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, Jaspers MW, Koning CC, Oldenburger F, Langeveld NE, Hart AA, Bakker PJ, Caron HN, van Leeuwen FE. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. Jama. 297: 2705-15. PMID 17595271 DOI: 10.1001/Jama.297.24.2705  0.4
2007 van Dalen EC, Caron HN, Kremer LC. Prevention of anthracycline-induced cardiotoxicity in children: the evidence. European Journal of Cancer (Oxford, England : 1990). 43: 1134-40. PMID 17383867 DOI: 10.1016/J.Ejca.2007.01.040  0.4
2007 Cardous-Ubbink MC, Heinen RC, Bakker PJ, van den Berg H, Oldenburger F, Caron HN, Voûte PA, van Leeuwen FE. Risk of second malignancies in long-term survivors of childhood cancer. European Journal of Cancer (Oxford, England : 1990). 43: 351-62. PMID 17141498 DOI: 10.1016/j.ejca.2006.10.004  0.4
2007 Jaspers MWM, Van den Bos C, Heinen RC, Bakker PJM, Geenen MM, Kremer LC, Van Leeuwen F, Caron HN. Development of a national protocol to screen Dutch cancer survivors on late cancer treatment effects International Journal of Medical Informatics. 76: 297-305. PMID 16533618 DOI: 10.1016/j.ijmedinf.2006.02.002  0.4
2007 Van Dalen E, Caron HN, Kremer LCM. Anthracyclines versus no anthracyclines for childhood cancer Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.CD006647  0.4
2007 Kremer LCM, Cardous-Ubbink MC, Geenen MM, Van Leeuwen FE, Caron HN. In reply [2] Journal of the American Medical Association. 298: 1635-1636.  0.4
2006 van Dalen EC, van der Pal HJ, Caron HN, Kremer LC. Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy. The Cochrane Database of Systematic Reviews. CD005008. PMID 17054232 DOI: 10.1002/14651858.CD005008.pub2  0.4
2006 van Dalen EC, Michiels EM, Caron HN, Kremer LC. Different anthracycline derivates for reducing cardiotoxicity in cancer patients. The Cochrane Database of Systematic Reviews. CD005006. PMID 17054231 DOI: 10.1002/14651858.CD005006.pub2  0.4
2006 van Dalen EC, van den Brug M, Caron HN, Kremer LC. Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials. European Journal of Cancer (Oxford, England : 1990). 42: 3199-205. PMID 17011186 DOI: 10.1016/J.Ejca.2006.08.002  0.4
2006 van Dalen EC, van der Pal HJ, Kok WE, Caron HN, Kremer LC. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. European Journal of Cancer (Oxford, England : 1990). 42: 3191-8. PMID 16987655 DOI: 10.1016/J.Ejca.2006.08.005  0.4
2006 van Dalen EC, van der Pal HJ, van den Bos C, Kok WE, Caron HN, Kremer LC. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines. European Journal of Cancer (Oxford, England : 1990). 42: 2549-53. PMID 16919450 DOI: 10.1016/J.Ejca.2006.04.014  0.4
2006 Opocher E, Kremer LC, Da Dalt L, van de Wetering MD, Viscardi E, Caron HN, Perilongo G. Prognostic factors for progression of childhood optic pathway glioma: a systematic review. European Journal of Cancer (Oxford, England : 1990). 42: 1807-16. PMID 16809032 DOI: 10.1016/J.Ejca.2006.02.022  0.4
2006 Blokker RS, Smit LME, Van Den Bos C, Overberg PC, Caron HN, Kaspers GJL. A boy with acute cerebellar ataxia without opsoclonus caused by neuroblastoma | Een jongen met acute cerebellaire ataxie zonder opsoclonus, door een neuroblastoom Nederlands Tijdschrift Voor Geneeskunde. 150: 799-803. PMID 16649400  0.4
2006 Frakking FNJ, van de Wetering MD, Brouwer N, Dolman KM, Geissler J, Lemkes B, Caron HN, Kuijpers TW. The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia European Journal of Cancer. 42: 909-916. PMID 16517152 DOI: 10.1016/j.ejca.2005.10.027  0.4
2006 Stam H, Grootenhuis MA, Brons PP, Caron HN, Last BF. Health-related quality of life in children and emotional reactions of parents following completion of cancer treatment. Pediatric Blood & Cancer. 47: 312-9. PMID 16261599 DOI: 10.1002/Pbc.20661  0.4
2006 Bierau J, van Gennip AH, Leen R, Meinsma R, Caron HN, van Kuilenburg AB. Cyclopentenyl cytosine-induced activation of deoxycytidine kinase increases gemcitabine anabolism and cytotoxicity in neuroblastoma. Cancer Chemotherapy and Pharmacology. 57: 105-13. PMID 16133534 DOI: 10.1007/s00280-005-0005-8  0.4
2006 De Ruijter AJM, Leen R, Hoebink J, Caron HN, Van Kuilenburg ABP. Antagonistic effects of sequential administration of BL1521, a histone deacetylase inhibitor, and gemcitabine to neuroblastoma cells Cancer Letters. 233: 240-246. PMID 15907366 DOI: 10.1016/J.Canlet.2005.03.016  0.4
2006 Stam H, Grootenhuis MA, Caron HN, Last BF. Quality of life and current coping in young adult survivors of childhood cancer: Positive expectations about the further course of the disease were correlated with better quality of life Psycho-Oncology. 15: 31-43. PMID 15751002 DOI: 10.1002/Pon.920  0.4
2006 Yalçyn B, Van Dalen EC, Caron HN, Kremer LCM. High dose chemotherapy and autologous stem cell rescue for children with high risk neuroblastoma Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.CD006301  0.4
2005 de Ruijter AJ, Meinsma RJ, Bosma P, Kemp S, Caron HN, van Kuilenburg AB. Gene expression profiling in response to the histone deacetylase inhibitor BL1521 in neuroblastoma. Experimental Cell Research. 309: 451-67. PMID 16084510 DOI: 10.1016/J.Yexcr.2005.06.024  0.4
2005 Merks JH, Smets AM, Van Rijn RR, Kobes J, Caron HN, Maas M, Hennekam RC. Prevalence of rib anomalies in normal Caucasian children and childhood cancer patients. European Journal of Medical Genetics. 48: 113-29. PMID 16053903 DOI: 10.1016/j.ejmg.2005.01.029  0.4
2005 van Dalen EC, van der Pal HJ, Reitsma JB, de Winter RJ, Helbing WA, Ottenkamp J, Caron HN, Kremer LC. Management of asymptomatic anthracycline-induced cardiac damage after treatment for childhood cancer: a postal survey among Dutch adult and pediatric cardiologists. Journal of Pediatric Hematology/Oncology. 27: 319-22. PMID 15956885 DOI: 10.1097/01.Mph.0000170887.27958.27  0.4
2005 van de Wetering MD, van Woensel JBM, Kremer LCM, Caron HN. Prophylactic antibiotics for preventing early Gram-positive central venous catheter infections in oncology patients, a Cochrane systematic review Cancer Treatment Reviews. 31: 186-196. PMID 15944048 DOI: 10.1016/j.ctrv.2004.12.004  0.4
2005 Van De Wetering MD, De Witte MA, Kremer LCM, Offringa M, Scholten RJPM, Caron HN. Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: A systematic review of randomised controlled trials European Journal of Cancer. 41: 1372-1382. PMID 15913983 DOI: 10.1016/j.ejca.2005.03.006  0.4
2005 Buwalda J, Freling NJ, Blank LE, Balm AJ, Bras J, Voûte PA, Caron HN, Schouwenburg PF, Merks JH. AMORE protocol in pediatric head and neck rhabdomyosarcoma: descriptive analysis of failure patterns. Head & Neck. 27: 390-6. PMID 15825203 DOI: 10.1002/Hed.20164  0.4
2005 Houtzager BA, Grootenhuis MA, Caron HN, Last BF. Sibling self-report, parental proxies, and quality of life: The importance of multiple informants for siblings of a critically ill child Pediatric Hematology and Oncology. 22: 25-40. PMID 15770829 DOI: 10.1080/08880010590896233  0.4
2005 Ouwehand K, De Ruijter AJM, Van Bree C, Caron HN, Van Kuilenburg ABP. Histone deacetylase inhibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins Febs Letters. 579: 1523-1528. PMID 15733867 DOI: 10.1016/J.Febslet.2005.01.058  0.4
2005 Merks JHM, Caron HN, Hennekam RCM. High incidence of malformation syndromes in a series of 1,073 children with cancer American Journal of Medical Genetics. 134: 132-143. PMID 15712196 DOI: 10.1002/ajmg.a.30603  0.4
2005 van Dalen EC, Caron HN, Dickinson HO, Kremer LC. Cardioprotective interventions for cancer patients receiving anthracyclines. The Cochrane Database of Systematic Reviews. CD003917. PMID 15674919 DOI: 10.1002/14651858.CD003917.pub2  0.4
2004 Van Limpt V, Schramm A, Lakeman A, Van Sluis P, Chan A, Van Noesel M, Baas F, Caron H, Eggert A, Versteeg R. The Phox2B homeobox gene is mutated in sporadic neuroblastomas Oncogene. 23: 9280-9288. PMID 15516980 DOI: 10.1038/Sj.Onc.1208157  0.4
2004 Houtzager BA, Oort FJ, Hoekstra-Weebers JEHM, Caron HN, Grootenhuis MA, Last BF. Coping and family functioning predict longitudinal psychological adaptation of siblings of childhood cancer patients Journal of Pediatric Psychology. 29: 591-605. PMID 15491981 DOI: 10.1093/Jpepsy/Jsh061  0.4
2004 De Ruijter AJM, Kemp S, Kramer G, Meinsma RJ, Kaufmann JO, Caron HN, Van Kuilenburg ABP. The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cells Biochemical Pharmacology. 68: 1279-1288. PMID 15345317 DOI: 10.1016/J.Bcp.2004.05.010  0.4
2004 Buwalda J, Blank LE, Schouwenburg PF, Copper MP, Strackee SD, Voûte PA, Merks JH, Caron HN. The AMORE protocol as salvage treatment for non-orbital head and neck rhabdomyosarcoma in children. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 30: 884-92. PMID 15336736 DOI: 10.1016/J.Ejso.2004.06.005  0.4
2004 Houtzager BA, Grootenhuis MA, Caron HN, Last BF. Quality of life and psychological adaptation in siblings of paediatric cancer patients, 2 years after diagnosis Psycho-Oncology. 13: 499-511. PMID 15295772 DOI: 10.1002/Pon.759  0.4
2004 Kremer LCM, Caron HN. Anthracycline cardiotoxicity in children New England Journal of Medicine. 351: 120-121. PMID 15247351 DOI: 10.1056/Nejmp048113  0.4
2004 Merks JH, Ceelie N, Caron HN, Hennekam RC. Neuroblastoma, maternal valproic acid use, in-vitro fertilization and family history of mosaic chromosome 22: Coincidence or causal relationship? Clinical Dysmorphology. 13: 197-198. PMID 15194961 DOI: 10.1097/01.Mcd.0000123123.89795.Fe  0.4
2004 Bierau J, Leen R, Van Gennip AH, Caron HN, Van Kuilenburg ABP. Determination of the deoxycytidine kinase activity in cell homogenates with a non-radiochemical assay using reversed-phase high performance liquid chromatography: Identification of a novel metabolite of 2-chlorodeoxyadenosine Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 805: 339-346. PMID 15135110 DOI: 10.1016/j.jchromb.2004.03.036  0.4
2004 Cardous-Ubbink MC, Heinen RC, Langeveld NE, Bakker PJ, Voûte PA, Caron HN, van Leeuwen FE. Long-term cause-specific mortality among five-year survivors of childhood cancer. Pediatric Blood & Cancer. 42: 563-73. PMID 15127410 DOI: 10.1002/pbc.20028  0.4
2004 van Dalen EC, van der Pal HJ, Bakker PJ, Caron HN, Kremer LC. Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children: a systematic review. European Journal of Cancer (Oxford, England : 1990). 40: 643-52. PMID 15010064 DOI: 10.1016/J.Ejca.2003.12.006  0.4
2004 Van De Wetering MD, Caron HN, Biezeveld M, Taminiau JAJM, Ten Kate FJ, Spanjaard L, Kuijpers TW. Severity of enterocolitis is predicted by IL-8 in paediatric oncology patients European Journal of Cancer. 40: 571-578. PMID 14962725 DOI: 10.1016/j.ejca.2003.10.021  0.4
2004 Bierau J, Van Gennip AH, Leen R, Zoetekouw L, Caron HN, Van Kuilenburg ABP. Cyclopentenyl cytosine sensitises SK-N-BE(2)c neuroblastoma cells to cladribine Nederlands Tijdschrift Voor Klinische Chemie En Laboratoriumgeneeskunde. 29: 271-272.  0.4
2004 Caron HN, Versteeg R. Scientific research in pediatric oncology within the Emma Children's Hospital AMC | Wetenschappelijk onderzoek in de kinderoncologie binnen het Emma Kinderziekenhuis AMC Tijdschrift Voor Kindergeneeskunde. 72: 42-48.  0.4
2003 Carlin S, Mairs RJ, McCluskey AG, Tweddle DA, Sprigg A, Estlin C, Board J, George RE, Ellershaw C, Pearson AD, Lunec J, Montaldo PG, Ponzoni M, van Eck-Smit BL, Hoefnagel CA, ... ... Caron HN, et al. Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 3338-44. PMID 12960120  0.4
2003 Versteeg R, van Schaik BDC, van Batenburg MF, Roos M, Monajemi R, Caron H, Bussemaker HJ, van Kampen AHC. The human transcriptome map reveals extremes in gene dentistry, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genes Genome Research. 13: 1998-2004. PMID 12915492 DOI: 10.1101/Gr.1649303  0.4
2003 Buwalda J, Schouwenburg PF, Blank LE, Merks JH, Copper MP, Strackee SD, Voûte PA, Caron HN. A novel local treatment strategy for advanced stage head and neck rhabdomyosarcomas in children: results of the AMORE protocol. European Journal of Cancer (Oxford, England : 1990). 39: 1594-602. PMID 12855267 DOI: 10.1016/S0959-8049(03)00363-0  0.4
2003 Houtzager BA, Grootenhuis MA, Hoekstra-Weebers JEHM, Caron HN, Last BF. Psychosocial functioning in siblings of paediatric cancer patients one to six months after diagnosis European Journal of Cancer. 39: 1423-1432. PMID 12826046 DOI: 10.1016/S0959-8049(03)00275-2  0.4
2003 Ambros IM, Benard J, Boavida M, Bown N, Caron H, Combaret V, Couturier J, Darnfors C, Delattre O, Freeman-Edward J, Gambini C, Gross N, Hattinger CM, Luegmayr A, Lunec J, et al. Quality assessment of genetic markers used for therapy stratification. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 2077-84. PMID 12775732 DOI: 10.1200/JCO.2003.03.025  0.4
2003 Van de Wetering MD, Kuijpers TW, Taminiau JAJM, Ten Kate FJW, Caron HN. Pseudomembranous and neutropenic enterocolitis in pediatric oncology patients Supportive Care in Cancer. 11: 581-586. PMID 12768402 DOI: 10.1007/s00520-003-0483-3  0.4
2003 Van Limpt VAE, Chan AJ, Van Sluis PG, Caron HN, Van Noesel CJM, Versteeg R. High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type International Journal of Cancer. 105: 61-69. PMID 12672031 DOI: 10.1002/Ijc.11047  0.4
2003 Molenaar JJ, Van Sluis P, Boon K, Versteeg R, Caron HN. Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma Genes Chromosomes and Cancer. 36: 242-249. PMID 12557224 DOI: 10.1002/Gcc.10166  0.4
2003 Bierau J, Van Gennip AH, Leen R, Helleman J, Caron HN, Van Kuilenburg ABP. Cyclopentenyl cytosine primes SK-N-BE(2)C neuroblastoma cells for cytarabine toxicity International Journal of Cancer. 103: 387-392. PMID 12471622 DOI: 10.1002/Ijc.10858  0.4
2003 De Ruijter AJM, Van Gennip AH, Caron HN, Kemp S, Van Kuilenburg ABP. Histone deacetylases (HDACs): Characterization of the classical HDAC family Biochemical Journal. 370: 737-749. PMID 12429021 DOI: 10.1042/Bj20021321  0.4
2002 Bierau J, Van Gennip AH, Leen R, Caron HN, Van Kuilenburg ABP. Retinoic acid reduces the cytotoxicity of cyclopentenyl cytosine in neuroblastoma cells Febs Letters. 527: 229-233. PMID 12220665 DOI: 10.1016/S0014-5793(02)03234-9  0.4
2002 Godfried MB, Veenstra M, Valent A, Sluis Pv, Voûte PA, Versteeg R, Caron HN. Lack of interstitial chromosome 1p deletions in clinically-detected neuroblastoma. European Journal of Cancer (Oxford, England : 1990). 38: 1513-9. PMID 12110498 DOI: 10.1016/S0959-8049(02)00137-5  0.4
2002 Godfried MB, Veenstra M, Sluis PV, Boon K, Asperen RV, Hermus MC, Schaik BDCV, Voûte TPA, Schwab M, Versteeg R, Caron HN. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2 Oncogene. 21: 2097-2101. PMID 11960382 DOI: 10.1038/Sj.Onc.1205259  0.4
2001 Van De Wetering MD, Poole J, Friedland I, Caron HN. Bacteraemia in a paediatric oncology unit in South Africa Medical and Pediatric Oncology. 37: 525-531. PMID 11745891 DOI: 10.1002/mpo.1246  0.4
2001 Heymans HSA, Caron HN. Cancer in children in the Netherlands (1989-1997) | Kanker op de kinderleeftijd in Nederland (1989-1997) Nederlands Tijdschrift Voor Geneeskunde. 145: 1442-1444. PMID 11503310  0.4
2001 Spieker N, Beitsma M, Van Sluis P, Chan A, Caron H, Versteeg R. Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1 Genes Chromosomes and Cancer. 31: 172-181. PMID 11319804 DOI: 10.1002/Gcc.1130  0.4
2001 Plantaz D, Vandesompele J, Van Roy N, Lastowska M, Bown N, Combaret V, Favrot MC, Delattre O, Michon J, Bénard J, Hartmann O, Nicholson JC, Ross FM, Brinkschmidt C, Laureys G, ... Caron H, et al. Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification. International Journal of Cancer. Journal International Du Cancer. 91: 680-6. PMID 11267980 DOI: 10.1002/1097-0215(200002)9999:9999<::Aid-Ijc1114>3.0.Co;2-R  0.4
2001 Boon K, Caron HN, van Asperen R, Valentijn L, Hermus MC, van Sluis P, Roobeek I, Weis I, Voûte PA, Schwab M, Versteeg R. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. The Embo Journal. 20: 1383-93. PMID 11250904 DOI: 10.1093/Emboj/20.6.1383  0.4
2001 Caron H, van Schaik B, van der Mee M, Baas F, Riggins G, van Sluis P, Hermus MC, van Asperen R, Boon K, Voûte PA, Heisterkamp S, van Kampen A, Versteeg R. The human transcriptome map: clustering of highly expressed genes in chromosomal domains. Science (New York, N.Y.). 291: 1289-92. PMID 11181992 DOI: 10.1126/Science.1056794  0.4
2001 Spieker N, Van Sluis P, Beitsma M, Boon K, Van Schaik BDC, Van Kampen AHC, Caron H, Versteeg R. The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32 Genomics. 71: 214-221. PMID 11161815 DOI: 10.1006/Geno.2000.6408  0.4
2001 Caron H, Spieker N, Godfried M, Veenstra M, Van Sluis P, De Kraker J, Vote P, Versteeg R. Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted Genes Chromosomes and Cancer. 30: 168-174. PMID 11135433 DOI: 10.1002/1098-2264(200102)30:2<168::Aid-Gcc1072>3.0.Co;2-E  0.4
2000 Van Kampen AHC, Van Schaik BDC, Pauws E, Michiels EMC, Ruijter JM, Caron HN, Versteeg R, Heisterkamp SH, Leunissen JAM, Baas F, Van Der Mee M. USAGE: A web-based approach towards the analysis of SAGE data Bioinformatics. 16: 899-905. PMID 11120679 DOI: 10.1093/Bioinformatics/16.10.899  0.4
2000 Van Limpt V, Chan A, Caron H, Van Sluis P, Boon K, Hermus MC, Versteeg R. SAGE analysis of neuroblastoma reveals a high expression of the human homologue of the Drosophila Delta gene Medical and Pediatric Oncology. 35: 554-558. PMID 11107116 DOI: 10.1002/1096-911X(20001201)35:6<554::Aid-Mpo13>3.0.Co;2-R  0.4
2000 Spieker N, Beitsma M, Sluis Pv, Roobeek I, Dunnen JTd, Speleman F, Caron H, Versteeg R. An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis. Genes, Chromosomes and Cancer. 27: 143-152. PMID 10612802 DOI: 10.1002/(Sici)1098-2264(200002)27:2<143::Aid-Gcc5>3.0.Co;2-E  0.36
1999 Caron HN, Van Noesel MM. Het neuroblastoom: De speurtocht naar klinisch-biologische entiteiten en de invloed op behandelkeuzes Tijdschrift Voor Kindergeneeskunde. 67: 200-205.  0.4
1998 Van den Berg H, Caron HN, Theunissen PHM, Theunissen PMV, Van der Schoot CE, Kroes W, Beverloo HB, Slater R. Bidirectional differentiation involving a cell with rearrangement of the MLL gene [1] Leukemia. 12: 102-103. PMID 9436928 DOI: 10.1038/Sj.Leu.2400899  0.4
1996 De Kraker J, Hoefnagel CA, Caron HN, Vos A, Bras J, Greve JC. 131I-MIBG as the treatment of choice of non-metastasized neuroblastoma | Jobenguaan-131-therapie als eerste keus bij het niet gemetastaseerde neuroblastoom Nederlands Tijdschrift Voor Geneeskunde. 140: 1997-2000. PMID 8965930  0.4
1996 Hofstra RM, Cheng NC, Hansen C, Stulp RP, Stelwagen T, Clausen N, Tommerup N, Caron H, Westerveld A, Versteeg R, Buys CH. No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma. Human Genetics. 97: 362-4. PMID 8786083 DOI: 10.1007/Bf02185773  0.4
1996 Caron H, van Sluis P, Buschman R, Pereira do Tanque R, Maes P, Beks L, de Kraker J, Voûte PA, Vergnaud G, Westerveld A, Slater R, Versteeg R. Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus. Human Genetics. 97: 834-7. PMID 8641706 DOI: 10.1007/Bf02346199  0.4
1996 Kushner BH, Cheung NKV, Caron HN, Voute PA, Versteeg R. Allelic loss of chromosome 1p in neuroblastoma [3] New England Journal of Medicine. 334: 1608-1609. PMID 8628350 DOI: 10.1056/NEJM199606133342415  0.4
1996 Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voûte PA, Versteeg R. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. The New England Journal of Medicine. 334: 225-30. PMID 8531999 DOI: 10.1056/Nejm199601253340404  0.4
1995 Caron H, Peter M, van Sluis P, Speleman F, de Kraker J, Laureys G, Michon J, Brugières L, Voûte PA, Westerveld A. Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Human Molecular Genetics. 4: 535-9. PMID 7633401 DOI: 10.1093/Hmg/4.4.535  0.4
1995 De Kraker J, Hoefnagel CA, Caron H, Valdés Olmos RA, Zsiros J, Heij HA, Voûte PA. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma. European Journal of Cancer (Oxford, England : 1990). 31: 600-2. PMID 7576977 DOI: 10.1016/0959-8049(95)00063-O  0.36
1995 Versteeg R, Caron H, Cheng NC, van der Drift P, Slater R, Westerveld A, Voûte PA, Delattre O, Laureys G, Van Roy N. 1p36: every subband a suppressor? European Journal of Cancer (Oxford, England : 1990). 31: 538-41. PMID 7576962 DOI: 10.1016/0959-8049(95)00037-J  0.4
1993 Caron H, van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voûte PA, Westerveld A, Versteeg R. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nature Genetics. 4: 187-90. PMID 8102298 DOI: 10.1038/Ng0693-187  0.4
1993 Caron H, Sluis Pv, Hoeve Mv, Kraker Jd, Bras J, Slater R, Mannens M, Voûte PA, Westerveld A, Versteeg R. Erratum: Corrigendum: Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification Nature Genetics. 4: 431-431. DOI: 10.1038/Ng0893-431A  0.4
1992 Caron HN, Abeling N, van Gennip A, de Kraker J, Voûte PA. Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimens. Medical and Pediatric Oncology. 20: 42-7. PMID 1727210  0.4
1992 Spanjaard L, Westra M, Caron HN, Overveg-Plandsoen WCG, De Groot CJ, Dankert J. Meningitis due to a multiply resistant streptococcus pneumoniae in a child in the Netherlands Scandinavian Journal of Infectious Diseases. 24: 117-118. PMID 1589719 DOI: 10.3109/00365549209048413  0.4
Show low-probability matches.